Clinical Trials in Georgia

Showing 4481-4500 of 14,426 trials

A Study to Evaluate Corneal Endothelial Cell Density (ECD) in Subjects With Dry Eye Disease (DED) Administering Miebo® (Perfluorohexyloctane Ophthalmic Solution) for 12 Months.

NCT06565650

A Randomized, Multicenter, Double-Masked, Saline-Controlled Trial to Evaluate Corneal Endothelial Cell Density in Subjects With Dry Eye Disease Administering Miebo® (Perfluorohexyloctane Ophthalmic Solution) for 12 Months

Dry Eye

Bausch & Lomb Incorporated216 participantsStarted Jul 2024

Glendale, California, United States • Murrieta, California, United States • Newport Beach, California, United States +9 more locations

RECRUITINGPhase 363 miles

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

NCT05184335

This study is to evaluate the effect and safety of Brilaroxazine in patients with acute schizophrenia compared to the placebo short and long-term. Brilaroxazine will be given at fixed doses of 15 mg or 50 mg once daily over 4 weeks, then in the long-term flexible doses 15-50mg daily over a period of 52 weeks.

Schizophrenia

Reviva Pharmaceuticals690 participantsStarted Jan 2022

Phoenix, Arizona, United States • Bentonville, Arkansas, United States • Little Rock, Arkansas, United States +15 more locations

A Study to Evaluate Corneal Endothelial Cell Density (ECD) in Subjects With Dry Eye Disease (DED) Administering Miebo® (Perfluorohexyloctane Ophthalmic Solution) for 12 Months.

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

Find Trials by Condition in Georgia

Phase 2 Open-label Extension Study of AOC 1020 in Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)

Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years

The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry

MP-376 (Aeroquin™, Levofloxacin for Inhalation) in Patients With Cystic Fibrosis

Endovascular Engineering ENGULF Study

Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation

DTA (Dopaminergic Therapy for Anhedonia) Study

Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype

To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody (DSA) Formation and the Development of Immune Activation (IA) in de Novo Kidney Transplant Recipients

Postpartum Glycemia in Women At Risk for Persistent Hyperglycemia

Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer

A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors

Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors

CYPRESS Efficacy and Safety Study Extension

Embecta AID System in Adults With Type 2 Diabetes

Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma

Study of Capivasertib in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer